brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC)

Overview of attention for article published in Journal for Immunotherapy of Cancer, March 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

news: 1 news outlet

twitter: 22 X users

Readers on

mendeley: 56 Mendeley

So far, Altmetric has seen 29 X posts from 22 X users, with an upper bound of 165,653 followers.

RT @OncoAlert: Not to be missed at #ESMO21 New results of expanded cohort 6 of the COSMIC-021 study from our @OncoAlert 🚨colleague @neeraj…

RT @jitcancer: New results of expanded cohort 6 of the COSMIC-021 study from @neerajaiims are coming up at #ESMO21 - In the meantime, dive…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 25 additional X posts.